Experiments for taxon Dracaena loureiri (AGAVACEAE)

Experiments (68 results)

Filters
Worktypes (17)
30
25
23
18
18
18
18
18
11
10
3
3
2
2
1
1
1
No match
Pharmacology (8)
9
9
7
3
2
1
1
36
No match
Compounds (30)
6
6
6
6
4
4
3
3
3
3
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
10
No match
Organisms (10)
27
14
9
8
3
2
2
1
1
1
No match
68 experiments
No experiment matches the selected filters.
ExperimentWorktypesPharmacologyOrganism (specimen)Compound
292705
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Dracaena loureiri (AGAVACEAE)
STILBENE,4-HYDROXY-3'-5'-DIMETHOXY:
292682
PHARMACOLOGY OF COMPOUND - IN VITRO
CYCLOOXYGENASE 1 INHIBITION
Dracaena loureiri (AGAVACEAE)
LOUREIRIOL
215981
PHARMACOLOGY OF COMPOUND - IN VITRO
ESTROGEN RECEPTOR BINDING EFFECT
Dracaena loureiri (AGAVACEAE)
LOUREIRIN B
292701
PHARMACOLOGY OF COMPOUND - IN VITRO
CYCLOOXYGENASE 2 INHIBITION
Dracaena loureiri (AGAVACEAE)
STILBENE,3'-4-DIHYDROXY-5'-METHOXY:
292686
PHARMACOLOGY OF COMPOUND - IN VITRO
CYCLOOXYGENASE 2 INHIBITION
Dracaena loureiri (AGAVACEAE)
CHROMAN-4-ONE,5-7-DIHYDROXY-3-(4-HYDROXY-BENZYL):
880851
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Dracaena loureiri (AGAVACEAE)
762057
REVIEW OF
Dracaena loureiri (AGAVACEAE)
292690
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Dracaena loureiri (AGAVACEAE)
CHALCONE,DIHYDRO: 2-4'-DIHYDROXY-4-6-DIMETHOXY:
298341
ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Dracaena loureiri (AGAVACEAE)
CHROMAN-4-ONE,3-5-7-TRIHYDROXY-3-(4-HYDROXY-BENZYL):
292706
PHARMACOLOGY OF COMPOUND - IN VITRO
CYCLOOXYGENASE 1 INHIBITION
Dracaena loureiri (AGAVACEAE)
STILBENE,4-HYDROXY-3'-5'-DIMETHOXY:
880855
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Dracaena loureiri (AGAVACEAE)
LOUREIRIN D
402407
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Dracaena loureiri (AGAVACEAE)
PINOCEMBRIN,S(2):
215977
PHARMACOLOGY OF COMPOUND - IN VITRO
ESTROGEN RECEPTOR BINDING EFFECT
Dracaena loureiri (AGAVACEAE)
CHALCONE,DIHYDRO: 4-4'-DIHYDROXY-2-6-DIMETHOXY:
215985
PHARMACOLOGY OF COMPOUND - IN VITRO
ESTROGEN RECEPTOR BINDING EFFECT
Dracaena loureiri (AGAVACEAE)
EUCOMOL
292696
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Dracaena loureiri (AGAVACEAE)
CHALCONE,DIHYDRO: 4-4'-6-TRIHYDROXY-2-METHOXY:
292689
PHARMACOLOGY OF COMPOUND - IN VITRO
CYCLOOXYGENASE 2 INHIBITION
Dracaena loureiri (AGAVACEAE)
CHALCONE,DIHYDRO: 4-4'-DIHYDROXY-2-6-DIMETHOXY:
402411
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Dracaena loureiri (AGAVACEAE)
FLAVAN,2(R): 4'-HYDROXY-7-METHOXY:
215976
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Dracaena loureiri (AGAVACEAE)
CHALCONE,DIHYDRO: 4-4'-DIHYDROXY-2-6-DIMETHOXY:
215982
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Dracaena loureiri (AGAVACEAE)
LOUREIRIN D
402405
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Dracaena loureiri (AGAVACEAE)
FLAVONE,4'-7-DIHYDROXY:
1061604
PHARMACOLOGY OF EXTRACT - IN VIVO
TOXIC EFFECT(GENERAL)
Dracaena loureiri (AGAVACEAE)
292704
PHARMACOLOGY OF COMPOUND - IN VITRO
CYCLOOXYGENASE 2 INHIBITION
Dracaena loureiri (AGAVACEAE)
STILBENE,3'-4-DIHYDROXY-5'-METHOXY:
215987
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Dracaena loureiri (AGAVACEAE)
CHROMAN-4-ONE,7-HYDROXY-3-(4-HYDROXY-BENZYL)-5-METHOXY:
92144
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FORINFRARED SPECTRUM REPORTED FOR
Dracaena loureiri (AGAVACEAE)
DRACAENONE,10-HYDROXY-11-METHOXY:
292693
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Dracaena loureiri (AGAVACEAE)
CHALCONE,DIHYDRO: 4'-HYDROXY-2-4-6-TRIMETHOXY:
292685
PHARMACOLOGY OF COMPOUND - IN VITRO
CYCLOOXYGENASE 1 INHIBITION
Dracaena loureiri (AGAVACEAE)
CHROMAN-4-ONE,5-7-DIHYDROXY-3-(4-HYDROXY-BENZYL):
880848
VOUCHER SPECIMEN REPORTED FOR
Dracaena loureiri (AGAVACEAE)
1171460
ANTIFERTILITYMEDICINAL FOLKLORE REPORTED FOR
FEMALE DISORDERS(UNSPECIFIED)
Dracaena loureiri (AGAVACEAE)
292700
PHARMACOLOGY OF COMPOUND - IN VITRO
CYCLOOXYGENASE 1 INHIBITION
Dracaena loureiri (AGAVACEAE)
STILBENE,3'-4-DIHYDROXY-5'-METHOXY:
880850
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Dracaena loureiri (AGAVACEAE)
292691
PHARMACOLOGY OF COMPOUND - IN VITRO
CYCLOOXYGENASE 1 INHIBITION
Dracaena loureiri (AGAVACEAE)
CHALCONE,DIHYDRO: 2-4'-DIHYDROXY-4-6-DIMETHOXY:
402406
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Dracaena loureiri (AGAVACEAE)
FLAVANONE,2(S): 7-HYDROXY:
292707
PHARMACOLOGY OF COMPOUND - IN VITRO
CYCLOOXYGENASE 2 INHIBITION
Dracaena loureiri (AGAVACEAE)
STILBENE,4-HYDROXY-3'-5'-DIMETHOXY:
402412
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Dracaena loureiri (AGAVACEAE)
EUCOMOL,3(R):
215986
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Dracaena loureiri (AGAVACEAE)
CHROMAN-4-ONE,5-7-DIHYDROXY-3-(4-HYDROXY-BENZYL):
292699
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Dracaena loureiri (AGAVACEAE)
STILBENE,3'-4-DIHYDROXY-5'-METHOXY:
292697
PHARMACOLOGY OF COMPOUND - IN VITRO
CYCLOOXYGENASE 1 INHIBITION
Dracaena loureiri (AGAVACEAE)
CHALCONE,DIHYDRO: 4-4'-6-TRIHYDROXY-2-METHOXY:
880854
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Dracaena loureiri (AGAVACEAE)
LOUREIRIN C
292684
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Dracaena loureiri (AGAVACEAE)
CHROMAN-4-ONE,5-7-DIHYDROXY-3-(4-HYDROXY-BENZYL):
402404
VOUCHER SPECIMEN REPORTED FOR
Dracaena loureiri (AGAVACEAE)
292692
PHARMACOLOGY OF COMPOUND - IN VITRO
CYCLOOXYGENASE 2 INHIBITION
Dracaena loureiri (AGAVACEAE)
CHALCONE,DIHYDRO: 2-4'-DIHYDROXY-4-6-DIMETHOXY:
402409
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Dracaena loureiri (AGAVACEAE)
CHALCONE,4-4'-DIHYDROXY-2'-METHOXY:
92145
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Dracaena loureiri (AGAVACEAE)
DRACAENONE,7-10-DIHYDROXY-11-METHOXY:
215989
PHARMACOLOGY OF COMPOUND - IN VITRO
ESTROGEN RECEPTOR BINDING EFFECT
Dracaena loureiri (AGAVACEAE)
CHROMAN-4-ONE,7-HYDROXY-3-(4-HYDROXY-BENZYL)-5-METHOXY:
292703
PHARMACOLOGY OF COMPOUND - IN VITRO
CYCLOOXYGENASE 1 INHIBITION
Dracaena loureiri (AGAVACEAE)
STILBENE,3'-4-DIHYDROXY-5'-METHOXY:
880849
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Dracaena loureiri (AGAVACEAE)
292687
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Dracaena loureiri (AGAVACEAE)
CHALCONE,DIHYDRO: 4-4'-DIHYDROXY-2-6-DIMETHOXY:
215979
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Dracaena loureiri (AGAVACEAE)
LOUREIRIN B
292694
PHARMACOLOGY OF COMPOUND - IN VITRO
CYCLOOXYGENASE 1 INHIBITION
Dracaena loureiri (AGAVACEAE)
CHALCONE,DIHYDRO: 4'-HYDROXY-2-4-6-TRIMETHOXY:
1061603
PHARMACOLOGY OF EXTRACT - IN VIVO
TOXIC EFFECT(GENERAL)
Dracaena loureiri (AGAVACEAE)
1264465
MEDICINAL FOLKLORE REPORTED FOR
ANTIPYRETIC ACTIVITY
Dracaena loureiri (AGAVACEAE)
215983
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Dracaena loureiri (AGAVACEAE)
EUCOMOL
292681
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Dracaena loureiri (AGAVACEAE)
LOUREIRIOL
292698
PHARMACOLOGY OF COMPOUND - IN VITRO
CYCLOOXYGENASE 2 INHIBITION
Dracaena loureiri (AGAVACEAE)
CHALCONE,DIHYDRO: 4-4'-6-TRIHYDROXY-2-METHOXY:
402410
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Dracaena loureiri (AGAVACEAE)
FLAVAN,2(R): 4'-7-DIHYDROXY:
880853
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Dracaena loureiri (AGAVACEAE)
LOUREIRIN B
92146
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Dracaena loureiri (AGAVACEAE)
CHROMANE,7-HYDROXY-3-(4-HYDROXY-BENZYL):
215988
PHARMACOLOGY OF COMPOUND - IN VITRO
ESTROGEN RECEPTOR BINDING EFFECT
Dracaena loureiri (AGAVACEAE)
CHROMAN-4-ONE,5-7-DIHYDROXY-3-(4-HYDROXY-BENZYL):
298342
ISOLATION AND IDENTIFICATION OF
Dracaena loureiri (AGAVACEAE)
RESVERATROLPTEROSTILBENELOUREIRIN DCHALCONE,DIHYDRO: 4-4'-DIHYDROXY-2-6-DIMETHOXY:CHALCONE,DIHYDRO: 2-4'-DIHYDROXY-4-6-DIMETHOXY:LOUREIRIN BPINOSTILBENECHROMAN-4-ONE,5-7-DIHYDROXY-3-(4-HYDROXY-BENZYL):
292702
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Dracaena loureiri (AGAVACEAE)
STILBENE,3'-4-DIHYDROXY-5'-METHOXY:
880852
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Dracaena loureiri (AGAVACEAE)
LOUREIRIN A
402408
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Dracaena loureiri (AGAVACEAE)
FLAVONONE,2(S): 4'-7-DIEHYDROXY-5-METHOXY:
215980
PHARMACOLOGY OF COMPOUND - IN VITRO
ESTROGEN RECEPTOR BINDING EFFECT
Dracaena loureiri (AGAVACEAE)
CHALCONE,DIHYDRO: 2-4'-DIHYDROXY-4-6-DIMETHOXY:
215978
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Dracaena loureiri (AGAVACEAE)
CHALCONE,DIHYDRO: 2-4'-DIHYDROXY-4-6-DIMETHOXY:
215984
PHARMACOLOGY OF COMPOUND - IN VITRO
ESTROGEN RECEPTOR BINDING EFFECT
Dracaena loureiri (AGAVACEAE)
LOUREIRIN D
292695
PHARMACOLOGY OF COMPOUND - IN VITRO
CYCLOOXYGENASE 2 INHIBITION
Dracaena loureiri (AGAVACEAE)
CHALCONE,DIHYDRO: 4'-HYDROXY-2-4-6-TRIMETHOXY:
292688
PHARMACOLOGY OF COMPOUND - IN VITRO
CYCLOOXYGENASE 1 INHIBITION
Dracaena loureiri (AGAVACEAE)
CHALCONE,DIHYDRO: 4-4'-DIHYDROXY-2-6-DIMETHOXY:
292683
PHARMACOLOGY OF COMPOUND - IN VITRO
CYCLOOXYGENASE 2 INHIBITION
Dracaena loureiri (AGAVACEAE)
LOUREIRIOL